Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-19-00342R2_FINAL_Gifford_02022020.pdf
[2] https://pubmed.ncbi.nlm.nih.gov/31761739-answering-the-call-to-address-cystic-fibrosis-treatment-burden-in-the-era-of-highly-effective-cftr-modulator-therapy/?from_single_result=Answering%20the%20call%20to%20address%20cystic%20fibrosis%20treatment%20burden%20in%20the%20era%20of%20highly%20effective%20CFTR%20modulator%20therapy
[3] https://www.ecfs.eu/research-article-keywords/modulator
[4] https://www.ecfs.eu/research-article-keywords/survey
[5] https://www.ecfs.eu/research-article-keywords/treatment-burden
[6] https://www.ecfs.eu/research-article-keywords/withdrawal-study
[7] https://www.ecfs.eu/resource-guideline-type/other-guidelines